The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Telomerase is not an oncogene
Abstract
In the decade since the telomere hypothesis of cellular aging was proposed, the two essential genes for human telomerase were cloned and characterized, allowing experimental proof of the causal relationships between telomere loss and replicative senescence, and telomerase activation and immortalization. These relationships were established using a variety of cultured human cell types from both normal and tumor tissues, and were largely confirmed in the telomerase knockout mouse. Taken together, the data provide strong support for the potential utility of telomerase detection and inhibition for cancer, and telomerase activation for degenerative diseases. The specificity of the promoter for the telomerase catalytic gene and the antigenicity of the protein product, hTERT, provide additional strategies for killing telomerase-positive tumor cells. Unfortunately, the strong link between telomerase and cancer has led some to confuse telomerase activation with cancer, and others to overstate the cancer risk of telomerase activation therapies for degenerative diseases. This review clarifies the difference between telomerase, which does not cause growth deregulation, and oncogenes, which do. It also addresses the concept of telomerase repression as a tumor suppressor mechanism early in life, with detrimental tissue degeneration and tumor-promoting consequences late in life. This extended view of the telomere hypothesis helps explain how telomerase inhibition can be therapeutic in cance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A point that should not be forgotten is that hTERT is not in the category of oncogenes [116,128].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [128]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“…not an oncogene. hTERT and telomerase activity are expressed in normal immortal human embryonic stem cells (Amit et al., 2000), in germline cells (Kim et al., 1994; Wright et al., 1996), and in dozens of somatic cells immortalized by hTERT transduction (Table 1), all without signs of aberrant…”
BackgroundSelf-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Self-citationThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · cited 2×
“There is also intriguing cell and animal data for the potential of telomerase activation in degenerative diseases (Funk et al., 2000; Jiang et al., 1999; Rudolph et al., 1999b), supported by the human dyskeratosis congenita genetic evidence (Vulliamy et al., 2001).”
BackgroundResultEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“…been largely substantiated by the phenotype of the late generation telomerase knockout mouse (Gonzalez-Suarez et al., 2000; Herrera et al., 1999; Lee et al., 1998; Rudolph et al., 1999a), which shares remarkable similarities to the phenotype of the autosomal dominant form of dyskeratosis…”
BackgroundHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853
Research works printed but not linked: 55
- Amit M, Carpenter MK, Inokuma MS, Chiu C-P, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA . 2000 Dev. Biol. 227: 271–278 · DOI
- Bandyopadhyay D, Timchenko N, Suwa T, Hornsby PJ, Campisi J, Medrano EE . 2001 Exp. Gerontol. 36: 1265–1275 · DOI
- Blackburn EH . 2001 Cell 106: 661–673 · DOI
- Blackburn EH, Szostak JW . 1989 Ann. Rev. Genet. 23: 163–194 · DOI
- Bodnar A, Kim NW, Effros RB, Chiu C-P . 1996 Exp. Cell Res. 228: 58–64 · DOI
- Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR . 1997 Hum. Mol. Gen. 6: 1–16 · DOI
- Campisi J . 1997 Eur. J. Cancer 33: 703–709 · DOI
- Chen J-L, Blasco MA, Greider CW . 2000 Cell 100: 503–514 · DOI · Paper page
- Choi D, Whittier PS, Oshima J, Funk WD . 2001 FASEB J. 15: 1014–1020 · DOI
- Cong YS, Bachetti S . 2000 J. Biol. Chem. 275: 35665–35668 · DOI
- Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG . 2000 Mol. Cell. Biol. 20: 1436–1447 · DOI · Paper page
- Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S, Moore MA . 2001 Exp. Cell Res. 268: 14–25 · DOI
- Funk WD, Wang CK, Shelton DN, Harley CB, Pagon GD, Hoeffler WK . 2000 Exp. Cell. Res. 258: 270–278 · DOI
- Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA . 2000 J. Exp. Med. 192: 1625–1636 · DOI
- Greider CW . 1996 Annu. Rev. Biochem. 65: 337–365 · DOI
- Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, de Lange T . 1999 Cell 97: 503–514 · DOI · Paper page
- Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JHM, Meyerson M, Weinberg RA . 1999 Nat. Med. 5: 1164–1170 · DOI
- Halvorsen RL, Leibowitz G, Levine F . 1999 Mol. Cell. Biol. 19: 1864–1870 · DOI
- Halvorsen TL, Beattie GM, Lopez AD, Hayek A, Levine F . 2000 J. Endrocrinol. 166: 103–109 · DOI
- Harley CB . 1991 Mut. Res. 256: 271–282 · DOI · Paper page
- Hooijberg E, Ruizendaal JJ, Snijders PJF, Kueter EWM, Walboomers JMM, Spits H . 2000 J. Immunol. 165: 4239–4245 · DOI
- Jiang X-R, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C-P . 1999 Nat. Genet. 21: 111–114 · DOI
- Jones CJ, Kipling D, Morris M, Hepburn P, Skinner J, Bounacer A, Wyllie FS, Ivan M, Bartek J, Wynford-Thomas D, Bond JA . 2000 Mol. Cell. Biol. 20: 5690–5699 · DOI · Paper page
- Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J . 2001 Proc. Natl. Acad. Sci. USA 98: 12072–12077 · DOI · Paper page
- Majumdar AS, Hughes DE, Lichtsteiner SP, Wang Z, Lebkowski JS, Vasserot AP . 2001 Gene Ther. 8: 568–578 · DOI
- McSharry BP, Jones CJ, Skinner JW, Kipling D, Wilkinson GWG . 2001 J. Gen. Virol. 82: 855–863 · DOI
- Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795 · DOI · Paper page
- Migliaccio M, Amacker M, Just T, Reichenbach P, Valmori D, Cerottini J-C, Romero P, Nabholz M . 2000 J. Immunol. 165: 4978–4984 · DOI
- Minev B, Hipp J, Firat H, Schmidt H, Langlade-Demoyen P, Zanetti M . 2000 Proc. Natl. Acad. Sci. USA 97: 4796–4801 · DOI
- Mitchell JR, Collins K . 2000 Mol. Cell. 6: 361–371 · DOI
- Nair SK, Hiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski J, Vieweg J, Gilboa E . 2000 Nat. Med. 6: 1011–1017 · DOI
- Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR . 1997 Science 277: 955–959 · DOI · Paper page
- O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver ARJ, Davies DC, Alsop AE, Neville AM, Jat PS . 2001 PNAS 98: 646–651 · DOI
- Ouellette MM, McDaniel LD, Wright WE, Shay JW, Schultz RA . 2000 Hum. Mol. Gen. 9: 403–411 · DOI
- Poole JC, Andrews LG, Tollefsbol TO . 2001 Gene 269: 1–12 · DOI
- Ranganathan V, Heine WF, Ciccone DN, Rudolph KL, Wu X, Chang S, Hai H, Ahearn IM, Livingston DM, Resnick I, Rosen F, Seemanova E, Jarolim P, DePinho RA, Weaver DT . 2001 Curr. Biol. 11: 962–966 · DOI
- Reynolds CP, Zuo JJ, Kim NW, Wang H, Lukens J, Matthay KK, Seeger RC . 1997 Eur. J. Cancer 33: 1929–1931 · DOI
- Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D . 2000 Mol. Ther. 2: 404–414 · DOI
- Seigneurin-Venin S, Bernard V, Ouellette MM, Mouly V, Wright WE, Tremblay J . 2000a Biochem. Biophys. Res. Commun. 7: 362–369 · DOI
- Seigneurin-Venin S, Bernard V, Tremblay JP . 2000b Gene Thera. 7: 619–623 · DOI
- Smith S, de Lange T . 2000 Curr. Biol. 10: 1299–1302 · DOI
- Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW . 1996 J. Invest. Dermatol. 106: 759–765 · DOI
- Thomas M, Yang L, Hornsby PJ . 2000 Nat. Biotech. 18: 39–42 · DOI
- Ulaner GA, Giudice LC . 1997 Mol. Hum. Reprod. 3: 769–773 · DOI
- Usselmann B, Newbold M, Morris AG, Nwokolo CU . 2001 Am. J. Gastroenterol. 96: 1106–1112 · DOI
- Vaziri H, Benchimol S . 1999 Oncogene 18: 7676–7680 · DOI
- von Zglinicki T . 2000 Ann. NY Acad. Sci. 99–110 · DOI
- Vonderheide RH, Hahn WC, Schultze JL, Nadler LM . 1999 Immunity 10: 673–679 · DOI
- Weng N-P, Granger L, Hodes RJ . 1997 Proc. Natl. Acad. Sci. USA 94: 10827–10832 · DOI
- Weng N-P, Levine BL, June CH, Hodes RJ . 1996 J. Exp. Med. 183: 2471–2479 · DOI
- Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW . 1996 Dev. Genet. 18: 173–179 · DOI · Paper page
- Wright WE, Shay JW . 2001 Curr. Opin. Genet. Dev. 11: 98–103 · DOI · Paper page
- Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, Bodnar A, Bronstein A, Chiu C-P, Herron GS . 1999 J. Biol. Chem. 274: 26141–26148 · DOI · Paper page
- Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T . 2001 J. Bone Miner. Res. 16: 1453–1464 · DOI
- Zhang X, Mar V, Harrington L, Robinson MO . 1999 Genes Dev. 13: 2388–2399 · DOI · Paper page
Cited by
Human Telomerase and Its Regulation
Cong, Y.-S., Wright, W. E., & Shay, J. W. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.3.407-425.2002 · Cited by 898
Telomerase and cancer therapeutics
Harley, C. B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2275 · Cited by 728
Self-citationTelomerase contributes to tumorigenesis by a telomere length-independent mechanism
Stewart, S. A., Hahn, W. C., O'Connor, B. F., Banner, E. N., Lundberg, A. S., Modha, P., Mizuno, H., Brooks, M. W., Fleming, M., Zimonjic, D. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182407599 · Cited by 431
Critical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385
Horikawa, I., & Barrett, J. C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg085 · Cited by 211
Metadata
- Authors
- Harley, C. B.
- Venue
- Oncogene
- Published
- 2002-01-21
- Volume
- 21
- Issue
- 4
- Pages
- 494-502
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 150
- References
- 24
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomerase is not an oncogene. https://app.cochat.ai/papers/10.1038/sj.onc.1205076
- The paper
- Harley, C. B. (2002). Telomerase is not an oncogene. Oncogene. https://doi.org/10.1038/sj.onc.1205076